About Immunovia

Immunovia is a strategic center for translational cancer research in Lund, Sweden. Immunovia’s strategy is to decipher a large amount of information in the blood and translate it into clinically useful tools to diagnose complex diseases such as cancer and to do this earlier and more accurately than previously possible. Immunovia’s core technology platform, IMMray™, is based on antibody microarray analysis.

Company Highlights
Year Founded

2007

icon-altEmployees

16

Location (HQ)

SWE

Since Last Funding

3 months

Monthly Website Visitors

13.9K

icon-altTotal Investment Amt

$50M

Last Funding Round

Grant

icon-altYoY Headcount Growth

-46.51%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Biotechnology

Oncology

Clinical Trials

Health Diagnostics